[{"NetIncomeLoss_1_Q2_USD":-36552000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":36636164.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":8845000.0,"InterestPaidNet_2_Q2_USD":1833000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":34607000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":124000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-214000.0,"Depreciation_2_Q2_USD":256000.0,"Depreciation_1_Q2_USD":131000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1511500.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":529000.0,"AssetsCurrent_0_Q2_USD":211338000.0,"OperatingLeaseExpense_2_Q2_USD":400000.0,"OperatingLeaseExpense_1_Q2_USD":200000.0,"LongTermDebt_0_Q2_USD":47685000.0,"LongTermDebtCurrent_0_Q2_USD":10345000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-540000.0,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_2_Q2_pure":0.75,"DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_1_Q2_pure":0.75,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":2315000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":104000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":516000.0,"CommonStockSharesIssued_0_Q2_shares":31329613.0,"Assets_0_Q2_USD":214579000.0,"ShareBasedCompensation_2_Q2_USD":8055000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2147000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":36468498.0,"GeneralAndAdministrativeExpense_1_Q2_USD":13722000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":26725000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":15.36,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-93000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":42178000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":21597000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":27.6,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2136000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":9000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":10000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.6738,"CommonStockValue_0_Q2_USD":3000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-12860000.0,"InterestPayableCurrent_0_Q2_USD":302000.0,"PropertyPlantAndEquipmentDisposals_2_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":256000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":14879587.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":516000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":3884000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0064,"OtherAssetsNoncurrent_0_Q2_USD":291000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":209669000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1375000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":589007000.0,"Liabilities_0_Q2_USD":82451000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":2143444.0,"DefinedContributionPlanCostRecognized_2_Q2_USD":600000.0,"DefinedContributionPlanCostRecognized_1_Q2_USD":200000.0,"OperatingLeaseLiability_0_Q2_USD":1855000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":33.88,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockSharesOutstanding_0_Q2_shares":29186169.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"AmortizationOfFinancingCosts_2_Q2_USD":698000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":587000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_2_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4237000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-78129000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":503000.0,"LiabilitiesCurrent_0_Q2_USD":39611000.0,"AccountsPayableCurrent_0_Q2_USD":5401000.0,"NonoperatingIncomeExpense_2_Q2_USD":-2492000.0,"NonoperatingIncomeExpense_1_Q2_USD":-1233000.0,"InterestExpense_2_Q2_USD":2528000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-77827000.0,"InterestExpense_1_Q2_USD":1256000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":516000.0,"LongTermDebtNoncurrent_0_Q2_USD":37340000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":24000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0725,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":209669000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":300000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":3000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":12352000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":803000.0,"NetIncomeLoss_2_Q2_USD":-71395000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1669000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":246000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-456882000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4100139.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":281000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2203000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"OperatingIncomeLoss_2_Q2_USD":-68903000.0,"OperatingIncomeLoss_1_Q2_USD":-35319000.0,"IncreaseDecreaseInInterestPayableNet_2_Q2_USD":-10000.0,"InvestmentIncomeInterest_2_Q2_USD":27000.0,"InvestmentIncomeInterest_1_Q2_USD":13000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":38.77,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":214579000.0,"PreferredStockSharesAuthorized_0_Q2_shares":40000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":655538.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8055000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":53000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":95105.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1390000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":480000.0,"OperatingExpenses_2_Q2_USD":68903000.0,"OperatingExpenses_1_Q2_USD":35319000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.96,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.0,"ProfitLoss_2_Q2_USD":-71395000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4125000.0,"StockholdersEquity_0_Q2_USD":132128000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":214000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":50000000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4237000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1436000.0,"Ticker":"PHAT","CIK":"1783183","name":"PHATHOM PHARMACEUTICALS, INC.","OfficialName":"Phathom Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"562637189.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210810"}]